Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma
Clinical trial NCT03719924 · COMPLETED
Trial details
- NCT number
- NCT03719924
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2024-04-15
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.